SecBot SecBot
SECBOTREPLAY Home › Report › KROS

KROS · Keros Therapeutics insiders executed a mixed cluster: one director…

Keros Therapeutics, Inc. · CLUSTER filed Aug 20, 2026 at 16:10 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Aug 20, 2026 at 16:10 ET

Keros Therapeutics insiders executed a mixed cluster: one director bought $10K worth of shares, while three C-suite officers and one director sold a combined $101K on the same day. The selling is concentrated among senior executives (CSO, CLO, VP Finance) at identical prices, suggesting coordinated liquidity or tax-related selling rather than a bearish signal, but the asymmetry between a small director buy and larger officer sells warrants attention. At $220M market cap, the $111K total is ~0.05% of market cap, trivial in magnitude, but the C-suite cluster sell pattern is notable given the company's pre-revenue biotech status and upcoming pipeline catalysts.

  • Director Jean Jacques Bienaime bought 1,000 shares at $10.27 for $10,270 on 2026-08-17.
  • CSO Lorena Lerner sold 3,568 shares at $10.29 for $36,715 on 2026-08-18.
  • CLO Esther Cho sold 4,485 shares at $10.29 for $46,151 on 2026-08-18.
  • VP Finance Annita Tanini sold 1,224 shares at $10.29 for $12,595 on 2026-08-18.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access